Salgado-Montiel L, Escobar-Bernal P, Vélez AJD

Language: Spanish
References: 12
Page: 320-324
PDF size: 191.89 Kb.

ABSTRACT

S. Schleiferi is a Gram-positive coccus that belongs to the group of coagulase-negative staphylococci and is part of the normal microflora of human skin and mucous membranes. In recent years, it has been considered an opportunistic nosocomial microorganism, with some reports of infection in humans that mostly correspond to postoperative infections in older adult patients with comorbidities. We present the case of a 56-year-old woman who developed hemodialysis catheter associated bacteriemia by S. Schleiferi in a tertiary care hospital in Cartagena de Indias, Colombia.

REFERENCES

1. Cosgrove SE. The relationship between antimicrobialresistance and patient outcomes: mortality, length ofhospital stay, and health care costs. Clin Infect Disan Off Publ Infect Dis Soc Am. 2006 Jan;42 Suppl 2:S82-9. https://doi.org/10.1086/499406.

2. Couto I, Pereira S, Miragaia M, Sanches IS, deLencastre H. Identification of clinical staphylococcalisolates from humans by internal transcribed spacerPCR. J Clin Microbiol. 2001 Sep;39(9): [3099-103]https://doi.org/10.1128/JCM.39.9.3099-3103.2001.

3. Kloos WE, Bannerman TL. Update on clinicalsignificance of coagulase-negative staphylococci. ClinMicrobiol Rev. 1994 Jan;7(1): 117-40. https://doi.org/10.1128/CMR.7.1.117.

4. Riquelme A, Arrese M, Soza A, Morales A, BaudrandR, Pérez-Ayuso RM, et al. Non-alcoholic fatty liverdisease and its association with obesity, insulinresistance and increased serum levels of C-reactiveprotein in Hispanics. Liver Int Off J Int Assoc StudyLiver. 2009 Jan;29(1): 82-8. https://doi.org/10.1111/j.1478-3231.2008.01823.x

5. Freney J, Brun Y, Bes M, Meugnier H, Grimont F,Grimont PAD, et al. Staphylococcus lugdunensissp. nov. and Staphylococcus schleiferi sp. nov., TwoSpecies from Human Clinical Specimens. Int J SystEvol Microbiol [Internet]. 1988;38(2): 168-72. Availablefrom: https://www.microbiologyresearch.org/content/journal/ijsem/10.1099/00207713-38-2-168 https://doi.org/10.1099/002077W13-38-2-168

6. Fleurette J, Bès M, Brun Y, Freney J, Forey F, Coulet M,et al. Clinical isolates of Staphylococcus lugdunensisand S. schleiferi: bacteriological characteristics andsusceptibility to antimicrobial agents. Res Microbiol.1989 Feb;140(2): 107-18. https://doi.org/10.1016/0923-2508(89)90044-2.

7. Jean-Pierre H, Darbas H, Jean-Roussenq A, BoyerG. Pathogenicity in two cases of Staphylococcusschleiferi, a recently described species. J Clin Microbiol.1989 Sep;27(9): 2110-1. https://doi.org/10.1128/jcm.27.9.2110-2111.1989.

8. Latorre M, Rojo PM, Unzaga MJ, Cisterna R.Staphylococcus schleiferi: a new opportunistic pathogen.Vol. 16, Clinical infectious diseases: an official publicationof the Infectious Diseases Society of America. UnitedStates; 1993. p. 589-90. https://doi.org/10.1093/clind/16.4.589.

9. Célard M, Vandenesch F, Darbas H, Grando J, Jean-Pierre H, Kirkorian G, et al. Pacemaker infectioncaused by Staphylococcus schleiferi, a member of thehuman preaxillary flora: four case reports. Clin InfectDis an Off Publ Infect Dis Soc Am. 1997 May;24(5):

10. 1014-5. https://doi.org/10.1093/clinids/24.5.1014.10. Leung MJ, Nuttall N, Mazur M, Taddei TL,McComish M, Pearman JW. Case of Staphylococcusschleiferi endocarditis and a simple scheme toidentify clumping factor-positive staphylococci. JClin Microbiol. 1999 Oct;37(10): 3353-6. https://doi.org/10.1128/JCM.37.10.3353-3356.1999.

11. Hernández JL, Calvo J, Sota R, Agüero J, García-Palomo JD, Fariñas MC. Clinical and microbiologicalcharacteristics of 28 patients with Staphylococcusschleiferi infection. Eur J Clin Microbiol Infect Dis OffPubl Eur Soc Clin Microbiol. 2001 Mar;20(3): 153-8.https://doi.org/10.1007/PL00011251.

12. Hébert GA. Hemolysins and other characteristicsthat help differentiate and biotype Staphylococcuslugdunensis and Staphylococcus schleiferi. J ClinMicrobiol. 1990 nov;28(11): 2425-31. https://doi.org/10.1128/jcm.28.11.2425-2431.1990.